Successful treatment of refractory cancer therapy-induced thrombocytopenia in a breast cancer patient using romiplostim N01: A case report
Romiplostim N01 effectively managed refractory CTIT in this case, showing rapid and sustained platelet recovery. This case demonstrates the potential of romiplostim N01 as a potential effective treatment for refractory CTIT.
Authors
- Peng Liu (ORCID: https://orcid.org/0009-0002-5578-1353)
- Jiajun Ling (ORCID: https://orcid.org/0000-0002-1384-761X)
- Bo Xie (ORCID: https://orcid.org/0000-0001-9374-863X)
- Yiming Jiang (ORCID: https://orcid.org/0000-0002-4894-177X)
- Lin Chen (ORCID: https://orcid.org/0000-0001-8274-9004)
- Enlai Dong
Institutions
- Guangzhou University of Chinese Medicine (CN)
- General Hospital of Guangzhou Military Command (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1097/md.0000000000043665
- Citations
- 2
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.63